Women’s Health Diagnostics Market Outlook 2029: Presents Market Insights & Depth Analysis
The global women health diagnostics market is significant growth at a CAGR 7.4% during the forecast period. The female bodysuffers from certain allergy, diseases, disorders, infections, anemia, and cancers such as autoimmune disease, renal disease, cardiovascular disease, and thyroid disease. There are number of cancer cases that are contributing to the increased use of gynecological surgical devices for the treatment of cancer and gynecological problems. The main types of cancer that commonly affect women’s health include cervical cancer, breast cancer, and ovarian cancer. In the female population, the breast cancer is the most common form of cancer occurring across the globe. The factors of breast cancer that propels the market growth include the slack of physical exercise, alcohol consumption, genetic history, menopausal changes, and exposure to ionizing radiations.
There are various therapies, treatments, and
medications that are used to reduce the risk of cancer such as hormone therapy
drugs that are enable to treat breast cancer. Moreover, tamoxifen and
raloxifene have been used for the prevention of breast cancer. The hormone
receptor (HR) positive breast cancers are those that contain estrogen receptor
(ER) and progesterone receptor (PR) due to this cancer grow in response to
these hormones and can be treated with hormone therapies. The inhibitors also
plays a prominent role in the breast cancer such as aromatase inhibitors that
consists exemestane and anastrozole. Due to changing levels of ovarian hormones
it makes less estrogen such inhibitors have been used.
Breast tissue consist main components of ducts,
fatty & fibrous connective tissue, and lobules. According to Cleveland
Clinic Organization, the 5% of breast cancer cases occur in women under 40
years of age and diagnosing breast cancer in younger women is more difficult
than older women, as the breast tissue are generally denser in young
women than the breast tissues found in older women. According to the World
Health Organization (WHO), breast cancer is the most frequent cancer that
affects nearly 2.1 million women each year across the globe. In 2018, the
mortality rate due to breast cancer reached to about 627,000; which covers
nearly 15% of all cancer deaths among women.
According to Breast Cancer Organization, in January
2019, there are more than 3.1 million women suffers from the breast cancer in
the US. The mortality rate of breast cancer is higher than any other cancer
such as skin cancer, lung cancer, and prostate cancer. In 2019, it is estimated
that about 30% of newly diagnosed cancers in women will be breast cancers. In
2019, the American Cancer Society estimates for breast cancer in the US for
2019 that about 268,600 new cases of invasive breast cancer will be diagnosed
in women and about 41,760 women will lose their livesfrom breast cancer.
To Request
a Sample of our Report on Women’s Health Diagnostics Market: https://www.omrglobal.com/request-sample/womens-health-diagnostics-market-size-share
Women Health Diagnostics Market- Segmentation
By Application
·
Breast Cancer Testing
·
Cervical Cancer Testing
·
Pregnancy & Fertility Testing
·
Ovarian Cancer Testing
·
Infectious Disease Testing
·
Ultrasound Tests
·
Sexually Transmitted Disease Testing
·
Others
By End-User
·
Diagnostic and Imaging Centers
·
Hospitals and Clinics
·
Home Care
A full Report of Women’s
Health Diagnostics Market is Available @ https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size-share
Women Health
Diagnostics Market– Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Abbott Laboratories
·
Becton, Dickinson and Co
·
BIOMÉRIEUX, INC.
·
Bio-Rad Laboratories, Inc.
·
BOSTON IMAGING
·
Canon Medical Systems Corp.
·
Carestream Health, Inc.
·
Cook Group Inc
·
DiaSorin S.p.A
·
Grifols, S.A.
·
Konica Minolta Healthcare Americas, Inc.
·
Laboratory Corp.
·
Myriad Genetics, Inc.
·
MedGyn Products, Inc.
·
Ortho Clinical Diagnostics
·
Philips International B.V.,
·
Quest Diagnostics
·
Thermo Fisher Scientific Inc.
·
Ziehm Imaging GmbH
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment